News | June 16, 2023
PrecisionLife announces strategic CNS drug development collaboration with Nanopharmaceutics
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Debut Biotechnology has outstanding enzyme search and design technology and a bio-manufacturing platform (precision fermentation, cell-free synthesis) using those enzymes
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
To enhance housing and enclosure design and performance for the Asia Pacific medical devices market, Kraiburg TPE offers the Thermoplast H HC/AP and HC/AD1/AP series
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
The combination will support clients in getting their end-to-end discovery and development programs delivered.
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The new company will utilize Teijin's drug discovery research technologies, facilities, equipment and personnel.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
